Aflac Incorporated (NYSE:AFL) Shares Bought by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC boosted its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 8.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,409 shares of the financial services provider's stock after acquiring an additional 2,975 shares during the period. Concurrent Investment Advisors LLC's holdings in Aflac were worth $4,271,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AFL. Vanguard Group Inc. boosted its stake in shares of Aflac by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock valued at $5,310,640,000 after acquiring an additional 653,275 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Aflac by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider's stock valued at $1,286,042,000 after buying an additional 288,482 shares during the last quarter. Northern Trust Corp raised its position in shares of Aflac by 22.9% in the fourth quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock valued at $754,700,000 after buying an additional 1,357,753 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Aflac by 11.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock valued at $543,154,000 after buying an additional 556,394 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Aflac in the fourth quarter valued at approximately $349,699,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Aflac Stock Up 0.3%

NYSE AFL traded up $0.34 during trading hours on Tuesday, reaching $103.22. 2,434,116 shares of the company traded hands, compared to its average volume of 2,153,806. Aflac Incorporated has a 12 month low of $88.00 and a 12 month high of $115.50. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $55.81 billion, a PE ratio of 16.13, a PEG ratio of 3.18 and a beta of 0.81. The company has a 50 day moving average of $104.14 and a two-hundred day moving average of $105.29.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The company had revenue of $3.40 billion for the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company's revenue was down 37.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.66 earnings per share. As a group, equities analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were issued a dividend of $0.58 per share. The ex-dividend date was Wednesday, May 21st. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.25%. Aflac's dividend payout ratio (DPR) is 36.25%.

Insiders Place Their Bets

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the sale, the director directly owned 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director directly owned 70,992 shares in the company, valued at approximately $7,496,045.28. This trade represents a 34.26% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 40,750 shares of company stock valued at $4,304,295. Company insiders own 0.80% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AFL. Wells Fargo & Company boosted their target price on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a report on Tuesday, May 6th. Morgan Stanley boosted their target price on shares of Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Wall Street Zen downgraded shares of Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. JPMorgan Chase & Co. raised their target price on shares of Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a research note on Tuesday. Finally, Keefe, Bruyette & Woods raised their target price on shares of Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a research note on Wednesday, May 7th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Aflac has an average rating of "Hold" and a consensus price target of $106.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.